Foreign-Trade Zone (FTZ) 230-Greensboro, North Carolina; Notification of Proposed Production Activity; Patheon Softgels (Pharmaceutical Products); High Point, North Carolina, 26947 [2018-12496]

Download as PDF Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices Estimate of Burden: Public reporting burden for this collection of information is estimated to average 30 hours per response. Estimated Number of Respondents: 1. Estimated Number of Responses per Respondent: 1. Estimated Total Annual Burden on Respondents: 30. Copies of this information collection can be obtained from MaryPat Daskal, Regulatory Team, Rural Development Innovation Center, at (202) 720–7853, FAX: (202) 720–8435. Email: MaryPat.Daskal@wdc.usda.gov. All responses to this notice will be summarized and included in the request for OMB approval. All comments will also become a matter of public record. Dated: May 29, 2018. Christopher A. McLean, Acting Administrator, Rural Utilities Service. [FR Doc. 2018–12415 Filed 6–8–18; 8:45 am] BILLING CODE P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–34–2018] daltland on DSKBBV9HB2PROD with NOTICES Foreign-Trade Zone (FTZ) 230— Greensboro, North Carolina; Notification of Proposed Production Activity; Patheon Softgels (Pharmaceutical Products); High Point, North Carolina The Piedmont Triad Partnership, grantee of FTZ 230, submitted a notification of proposed production activity to the FTZ Board on behalf of Patheon Softgels (Patheon), located in High Point, North Carolina. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on May 31, 2018. Patheon already has authority to produce certain prescription pharmaceutical products and soft gelatin capsules within Subzone 230C. Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited to the specific foreign-status materials/components and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt Patheon from customs duty payments on the foreign-status materials/components used in export production. On its domestic sales, for the foreign-status materials/components noted below and in the existing scope of authority, Patheon would be able to VerDate Sep<11>2014 19:19 Jun 08, 2018 Jkt 244001 choose the duty rates during customs entry procedures that apply to: Gelatin encapsulated ibuprofen capsules (dutyfree). Patheon would be able to avoid duty on foreign-status components which become scrap/waste. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The materials/components sourced from abroad include: Ponceau R4 (food coloring—for use only in production for export); ibuprofen active pharmaceutical ingredients; medium chain triglycerides; and, polyethylene glycol (duty rate ranges from 8.8ct/kg to 6.5%). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is July 23, 2018. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s website, which is accessible via www.trade.gov/ftz. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov or (202) 482–1963. Dated: June 5, 2018. Andrew McGilvray, Executive Secretary. [FR Doc. 2018–12496 Filed 6–8–18; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–37–2018] Foreign-Trade Zone 113—Ellis County, Texas; Application for Reorganization (Expansion of Service Area); Under Alternative Site Framework An application has been submitted to the Foreign-Trade Zones (FTZ) Board by the Ellis County Trade Zone Corporation, grantee of Foreign-Trade Zone 113, requesting authority to reorganize the zone to expand its service area under the alternative site framework (ASF) adopted by the FTZ Board (15 CFR Sec. 400.2(c)). The ASF is an option for grantees for the establishment or reorganization of zones and can permit significantly greater flexibility in the designation of new subzones or ‘‘usage-driven’’ FTZ sites PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 26947 for operators/users located within a grantee’s ‘‘service area’’ in the context of the FTZ Board’s standard 2,000-acre activation limit for a zone. The application was submitted pursuant to the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the FTZ Board (15 CFR part 400). It was formally docketed on June 4, 2018. FTZ 113 was approved by the FTZ Board on December 21, 1984 (Board Order 283, 50 FR 300, January 3, 1985) and reorganized under the ASF on September 24, 2010 (Board Order 1708, 75 FR 61706, October 6, 2010). The zone currently has a service area that includes Ellis County, Texas. The applicant is now requesting authority to expand the service area of the zone to include Navarro County, Texas, as described in the application. If approved, the grantee would be able to serve sites throughout the expanded service area based on companies’ needs for FTZ designation. The application indicates that the proposed expanded service area is adjacent to the Dallas/ Fort Worth Customs and Border Protection Port of Entry. In accordance with the FTZ Board’s regulations, Camille Evans of the FTZ Staff is designated examiner to evaluate and analyze the facts and information presented in the application and case record and to report findings and recommendations to the FTZ Board. Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is August 10, 2018. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to August 27, 2018. A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s website, which is accessible via www.trade.gov/ftz. For further information, contact Camille Evans at Camille.Evans@ trade.gov or (202) 482–2350. Dated: June 5, 2018. Andrew McGilvray, Executive Secretary. [FR Doc. 2018–12497 Filed 6–8–18; 8:45 am] BILLING CODE 3510–DS–P E:\FR\FM\11JNN1.SGM 11JNN1

Agencies

[Federal Register Volume 83, Number 112 (Monday, June 11, 2018)]
[Notices]
[Page 26947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12496]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-34-2018]


Foreign-Trade Zone (FTZ) 230--Greensboro, North Carolina; 
Notification of Proposed Production Activity; Patheon Softgels 
(Pharmaceutical Products); High Point, North Carolina

    The Piedmont Triad Partnership, grantee of FTZ 230, submitted a 
notification of proposed production activity to the FTZ Board on behalf 
of Patheon Softgels (Patheon), located in High Point, North Carolina. 
The notification conforming to the requirements of the regulations of 
the FTZ Board (15 CFR 400.22) was received on May 31, 2018.
    Patheon already has authority to produce certain prescription 
pharmaceutical products and soft gelatin capsules within Subzone 230C. 
Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited 
to the specific foreign-status materials/components and specific 
finished products described in the submitted notification (as described 
below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Patheon from customs 
duty payments on the foreign-status materials/components used in export 
production. On its domestic sales, for the foreign-status materials/
components noted below and in the existing scope of authority, Patheon 
would be able to choose the duty rates during customs entry procedures 
that apply to: Gelatin encapsulated ibuprofen capsules (duty-free). 
Patheon would be able to avoid duty on foreign-status components which 
become scrap/waste. Customs duties also could possibly be deferred or 
reduced on foreign-status production equipment.
    The materials/components sourced from abroad include: Ponceau R4 
(food coloring--for use only in production for export); ibuprofen 
active pharmaceutical ingredients; medium chain triglycerides; and, 
polyethylene glycol (duty rate ranges from 8.8ct/kg to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary at the address 
below. The closing period for their receipt is July 23, 2018.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW, 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's website, which is accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected] or (202) 482-1963.

    Dated: June 5, 2018.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2018-12496 Filed 6-8-18; 8:45 am]
 BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.